Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 5 - The Real Truth

Woman who died after refusing chemotherapy ‘adversely influenced’ by mother

Paloma Shemirani, 23, collapsed on July 19 last year and was taken to Royal Sussex County Hospital where she died five days later.

Evening Standard

Conspiracy theorist mother ‘influenced’ daughter to reject chemotherapy after she was diagnosed with cancer

Kate Shemirani’s conduct of care towards daughter Paloma described as ‘incomprehensible’ by a coroner

The Independent UK

Halsey gives chemotherapy update on rare health disorder

Halsey has opened up about going through more chemotherapy for her rare health disorder.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Halsey undergoing chemotherapy for rare T-cell disorder

The singer has been diagnosed with lupus and a rare T-cell lymphoproliferative disorder

The Independent UK

Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it

A Trump administration decision to repurpose an old chemotherapy drug for autism has surprised many experts — including the physician who recently proposed the idea

The Independent UK

Mother diagnosed with incurable cancer after pain dismissed by doctors

Simone Williamson was diagnosed with myeloma after years of being ‘fobbed off’

The Independent UK

Folinic Acid Secrets: Why Dr. Oz and iHerb Are Popularizing Leucovorin for Autism After Chemotherapy Success

Folinic acid gains attention as Dr. Oz and iHerb spotlight leucovorin's potential in autism after decades of chemotherapy use.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

‘I thought I had injured my back – but it was incurable blood cancer’

More than 33,000 people in the UK are living with myeloma, a type of incurable blood cancer that causes bone pain

The Independent UK

Dad diagnosed with stage 4 cancer after wife’s death from the illness

Paul Garratt lost his wife of 10 years to breast cancer in 2015 at the age of 31

The Independent UK

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Benzinga

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co (NYSE:BMY) shared interim Phase 2 data on pumitamig (BNT327/BMS986545) plus chemotherapy in patients with untreated extensive-stage small cell lung cancer (ES-SCLC).

Benzinga

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

On Sunday, AstraZeneca Plc (AZN) released results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial in previously untreated patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletion or exon 21 L858R mutations.

Benzinga

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC).

Benzinga

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data

On Friday, BioNTech SE (NASDAQ:BNTX) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug

On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed.

Evening Standard

Dermot Murnaghan ‘feeling pretty good’ after chemotherapy for stage four cancer

The TV presenter, who has been diagnosed with prostate cancer, said men should demand testing on the NHS.

LiveScience

Why do some people grow 'chemo curls' after cancer treatment?

After chemotherapy, some people get "chemo curls" and other changes to their hair texture and appearance. But why?

AAP

Mini hearts to save cancer survivors from heart disease

Lab-grown "mini hearts" the size of a grain of sand are being used to test new drugs researchers hope will protect breast cancer patients from heart failure.

Get all your
news in one place.

100's of premium titles.
One news app.

Motor1

How Designing Supercars Helped Gordon Murray Through Cancer

Gordon Murray can’t stop working. As he approaches 80 years old, Murray is still developing new supercars, and not even a cancer diagnosis took him away from the drafting table. One of Gordon Murray Automotive’s newest supercars—the S1 LM—was developed while its namesake was undergoing chemotherapy.

The Independent UK

Woman diagnosed with same cancer as late husband after stomach ache

Ann Lally and her late husband, Mike, were both diagnosed with advanced pancreatic cancer

Evening Standard

Parents who advised daughter against chemotherapy warned over inquest behaviour

Paloma Shemirani, 23, collapsed last July and was taken to hospital where she died five days later having earlier declined cancer treatment.

Benzinga

Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients

On Tuesday, Merck Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based chemotherapy.

Evening Standard

New drug ‘could boost effectiveness of chemotherapy’, developers say

It is hoped KCL-HO-1i can be trialled on humans, with researchers suggesting it could one day be a ‘valuable companion drug’ to chemotherapy.

The Independent UK

The new take-at-home drug that ‘could boost effectiveness of chemotherapy’

New medicine will spare some patients from more aggressive treatments

International Business Times

Secondhand Chemo Is Real: How Jim Mullowney Is Dealing With ChemWaste Crisis From Both People and Business Point of View

At the center of Pharma-Cycle's innovation is a patented packaging system designed to safely collect and manage human waste contaminated by chemotherapy drugs, waste that continues to emit cytotoxic chemicals long after a patient leaves the clinic.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.